Home > Authorities > Grants > Record #324931 > print

001     324931
005     20230214180622.0
024 7 _ |a G:(EU-Grant)731060
|d 731060
|2 CORDIS
024 7 _ |a G:(EU-Call)H2020-INFRAIA-2016-1
|d H2020-INFRAIA-2016-1
|2 CORDIS
024 7 _ |a corda__h2020::731060
|2 originalID
035 _ _ |a G:(EU-Grant)731060
150 _ _ |a Research Infrastructures for the control of vector-borne diseases
|y 2017-02-01 - 2022-06-30
371 _ _ |a LIVERPOOL SCHOOL OF TROPICAL MEDICINE
|d United Kingdom
|e http://www.liv.ac.uk/lstm/lstm.html
|v CORDIS
371 _ _ |a Fondation Health Sciences e-Training
|d Switzerland
|e http://hset.bio-med.ch
|v CORDIS
371 _ _ |a TROPIQ HEALTH SCIENCES
|d Netherlands
|e http://www.tropIQ.nl
|v CORDIS
371 _ _ |a Univerzitet u Novom Sadu, Poljoprivredni fakultet Novi Sad
|d Serbia
|e http://polj.uns.ac.rs
|v CORDIS
371 _ _ |a STICHTING KATHOLIEKE UNIVERSITEIT
|d Netherlands
|e http://www.ru.nl
|v CORDIS
371 _ _ |a Max Planck Society
|b MPG
|d Germany
|e http://www.mpg.de/en
|v CORDIS
371 _ _ |a University of Glasgow
|b University of Glasgow
|d United Kingdom
|e http://www.gla.ac.uk/
|v CORDIS
371 _ _ |a IDRYMA TECHNOLOGIAS KAI EREVNAS
|b FOUNDATION FOR RESEARCH AND TECHNOLOGYHELLAS
|d Greece
|e http://www.forth.gr
|v CORDIS
371 _ _ |a University of Zurich
|b UZH
|d Switzerland
|e http://www.uzh.ch/index_en.html
|v CORDIS
371 _ _ |a EUROPEAN MOLECULAR BIOLOGY LABORATORY
|b EMBL
|d Germany
|e http://www.embl.org
|v CORDIS
371 _ _ |a Institut Pasteur de Dakar
|b Institut Pasteur de Dakar
|d Senegal
|e http://www.pasteur.sn/
|v CORDIS
371 _ _ |a Institut Pasteur de Nouvelle Calédonie
|b IPNC
|d New Caledonia
|e https://www.institutpasteur.nc/
|v CORDIS
371 _ _ |a Ministère De La Santé
|b Ministère De La Santé
|d Burkina Faso
|e http://www.sante.gov.bf/
|v CORDIS
371 _ _ |a Institut Pasteur
|b Institut Pasteur
|d France
|e http://www.pasteur.fr/en
|v CORDIS
371 _ _ |a POLO D'INNOVAZIONE DI GENOMICA, GENETICA E BIOLOGIA SCARL
|b POLOGGB
|d Italy
|e http://www.pologgb.com
|v CORDIS
371 _ _ |a INSTITUT DE RECERCA I TECNOLOGIA AGROALIMENTARIES
|b INSTITUTE FOR FOOD AND AGRICULTURE RESEARCH AND TECHNOLOGY
|d Spain
|e http://www.irta.es
|v CORDIS
371 _ _ |a CENTRO AGRICOLTURA E AMBIENTE GIORGIO NICOLI SRL
|b CAA
|d Italy
|e http://www.caa.it
|v CORDIS
371 _ _ |a Imperial College of Science Technology and Medicine
|b Imperial
|d United Kingdom
|e http://www.imperial.ac.uk
|v CORDIS
371 _ _ |a Centre de Coopération Internationale en Recherche Agronomique pour le Développement
|b CIRAD
|d France
|e http://www.cirad.fr/en/home-page
|v CORDIS
371 _ _ |a Wageningen University
|b WU
|d Netherlands
|e http://www.wur.nl/
|v CORDIS
371 _ _ |a The Pirbright Institute
|b TPI
|d United Kingdom
|e http://www.pirbright.ac.uk
|v CORDIS
371 _ _ |a Institut de Recherche pour le Développement
|b IRD
|d France
|e https://www.ird.fr/
|v CORDIS
371 _ _ |a Charles University
|b Charles University
|d Czechia
|e http://www.cuni.cz/UKENG-1.html
|v CORDIS
371 _ _ |a Université des Sciences, des Techniques et des Technologies de Bamako
|b USTTB
|d Mali
|e http://www.usttb.edu.ml/index.php/
|v CORDIS
372 _ _ |a H2020-INFRAIA-2016-1
|s 2017-02-01
|t 2022-06-30
450 _ _ |a INFRAVEC2
|w d
|y 2017-02-01 - 2022-06-30
510 1 _ |0 I:(DE-588b)5098525-5
|a European Union
|2 CORDIS
680 _ _ |a The overall objective of the Infravec2 project is to integrate key specialized research facilities necessary for European excellence in insect vector biology, to open the infrastructure for European access, and to develop new vector control measures targeting the greatest threats to human health and animal industries. Infravec2 is an Advanced Community, following a four-year Starting Community lifecycle (FP7 Infravec1). Lack of access to key infrastructures limits European vector research and impedes development of vector control measures. Insect vectors transmit parasitic diseases such as malaria and leishmaniasis, and viral infections such as chikungunya, dengue, Zika, Japanese encephalitis and yellow fever. Vector-borne diseases, which have historically been a problem of tropical countries, now represent a threat for temperate regions of the world including much of Europe. The 24 consortium partners, including 4 commercial companies, hold the major European biosecure insectaries for experimental infection and containment of insect vectors under Containment Level 2 and 3 (CL2/CL3) conditions, other key insect vector facilities, and include front-line field sites in Africa, the Pacific, and the Americas. Infravec2 will implement comparable standards across the secure insectary facilities as a world first, improving exploitation of European vector infrastructures for research and public health, and will develop other innovative methodologies and technologies. Networking activities will assure that the project achieves full impact, producing a step change in European vector biology research and the product pipeline, and consolidating European global leadership in insect vectors. The goal of the Infravec2 project is to build a durable European infrastructure to control insect vector-borne disease, including with power to predict and prevent the inevitable next epidemic outbreak in advance.
909 C O |o oai:juser.fz-juelich.de:830632
|p authority:GRANT
|p authority
909 C O |o oai:juser.fz-juelich.de:830632
970 _ _ |a oai:dnet:corda__h2020::c6056512eac8bcdd1ee8f841a149287e
980 _ _ |a G
980 _ _ |a CORDIS
980 _ _ |a AUTHORITY

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21